ホーム > 市場調査レポート > 医薬品 > 動物用医薬 > アジアにおける動物医療に関する規制
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

アジアにおける動物医療に関する規制

Asian Animal Health Regulation

発行 PJB Publications Ltd.
出版日 2007年07月 商品コード 54131
ページ情報 英文  
価格
こちらの商品の販売は終了いたしました。

当商品の販売は、2011年08月03日を持ちまして終了しました。

原文目次

Abstract

"Historically, getting products approved in Japan has been slower than in other regions … However there has been some change in this recently ‘foreign’ data is becoming more acceptable."

This single volume report, is a concise summary of the legislative framework and the filing procedure for achieving product approval in Asian markets.

Key coverage

  • Take a detailed look at the legislative and regulatory framework in place - particularly for Japan and China.
  • Understand the filing procedures required to bring an animal drug product to market in Asia effectively and efficiently.
  • Use the report to plan a submission and to help you discuss your plans with your chosen local collaborator.
  • Discover the problems faced by the Chinese veterinary medicines industry and the recent regulations implemented that could mean opportunities for your business.

Key findings

Despite the differences compared with the EU and the US, many products are successfully authorized for sale in Japan, which remains a major commercial potential for any veterinary medicinal product that can be sold throughout the world.

The Chinese industry has an urgent need for standardization. As the market opens, China will be flooded with imported products. For domestic producers to be able to compete, the regulatory system needs urgent improvement.

Find out the main acts and regulations as well as guidance on getting approvals and practical tips to speed up the approval process.

Examine the regulatory culture in the rapidly expanding Indian market, which has been reluctant to adopt global policies due to the nature of that particular market. Changes since the last Animal Pharm report on the Indian animal health market are listed and discussed.

Chapters include

Legal framework, detailed data requirements, regulatory procedures in Japan for approval and licensing, where to find guidance on regulatory requirements, regulations in China, product registration and regulation in India.

Who should read this report?

This report will be an ideal guide for:

  • Newcomers to the regulatory profession
  • Generics manufacturers in or outside of Asia
  • Or drug developers wanting to market their products in Asia

Table of Contents

CHAPTER 1 - LEGAL FRAMEWORK

  • 1.1 Japanese Ministry of Agriculture, Forestry and Fisheries guidelines

CHAPTER 2 - DETAILED DATA REQUIREMENTS

  • 2.1 Data on details or origin or discovery (development) of the product and the status of its use in foreign countries
  • 2.2 Data on physical, chemical and biological properties, specifications and testing methods
  • 2.3 Data on stability
  • 2.4 Data on safety
  • 2.5 Data on clinical studies
  • 2.6 Residue studies

CHAPTER 3 - REGULATORY PROCEDURES IN JAPAN FOR APPROVAL AND LICENSING

CHAPTER 4 - WHERE TO FIND GUIDANCE ON JAPANESE REGULATORY REQUIREMENTS

CHAPTER 5 - REGULATIONS IN CHINA

  • 5.1 Chapter I: General Provisions
  • 5.2 Chapter II: Research and Development of New Veterinary Drugs
  • 5.3 Chapter III: Manufacture of Veterinary Drugs
  • 5.4 Chapter IV: Distribution of Veterinary Drugs
  • 5.5 Chapter V: Import and Export of Veterinary Drugs
  • 5.6 Chapter VI: Use of Veterinary Drugs
  • 5.7 Chapter VII: Supervision and Administration of Veterinary Drugs
  • 5.8 Chapter VIII: Legal Liability
  • 5.9 Chapter IX: Supplementary Provisions

CHAPTER 6 - PRODUCT REGISTRATION AND REGULATION IN INDIA

  • 6.1 Introduction
  • 6.2 Controlling bodies for product approval
    • 6.2.1 Central Government
    • 6.2.2 State Government
      • The Food and Drug Administration
  • 6.3 Procedures for registration
    • 6.3.1 Key registration requirements for a new product
    • 6.3.2 Application procedure
  • 6.4 Product Patent Protection
    • 6.4.1 Background
    • 6.4.2 Current Situation
  • 6.5 Harmonization
  • 6.6 Price control
    • 6.6.1 Pricing norms for scheduled formulations
    • 6.6.2 The Third Schedule
    • 6.6.3 Drug Policy, 1994
  • 6.7 Implications for the animal health industry
  • 6.8 Drugs and Cosmetics Act, 1940
  • 6.9 Drugs and Cosmetics Rules, 1945

LIST OF TABLES

  • Table 1.1: Safety and efficacy data requirements for veterinary products in Japan
  • Table 6.1: Effect of branding on pricing

LIST OF FIGURES

  • Figure 3.1: Approval procedure in Japan (1)
  • Figure 3.2: Approval procedure in Japan (2)
  • Figure 6.1: Pricing illustration
Back to Top